This week's European cannabis news revolves around low cost Latin American producers making inroads to the old continent
Germany-based Farmako signed a large deal for cannabis coming from Macedonian grower, NYSK Holdings, via Pharmacan Polska
Since June 2017, it has been possible for doctors to prescribe cannabis medications. In March 2018, the Greek Parliament approved a law authorising the cultivation and production of medical cannabis, prompting the Prime Minister of Greece, Alexis Tsipras to comment enthusiastically: “from now on, the country is turning its page.”
Under Prohibition, branding and formal marketing campaigns do not exist. There was no ‘halo’ effect from publicising a company through its products. This is set to change and the smart new cannabis producers will understand that their image cannot be faked, but must be built on transparency, fairness and the true quality of the product
Prohibition drives unfair, unhealthy behaviour in the market for cannabis. Disputes are handled outside the rule of law, leading to tens of thousands of violent deaths in impoverished areas of the world where there are few legal alternative income sources
Beyond the impact of individuals, what about the organisational cultures of post-prohibition cannabis companies? Too often, they are hierarchical, male-dominated, brutal places to work. Last Autumn, two friends from Catalonia...